ICU Medical (ICUI)

Healthcare · Medical Instruments & Supplies
$160.32 +2.00% on the day Market cap $4.3B 52-week range $112.50 to $192.85 Prices as of Oct 11, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
16% a year for 10 years

At a market value of $4.3B, ICU Medical's free cash flow of $92M (fiscal 2025) would need to grow about 16% a year for the stock to be worth today's price. That is faster than the company has grown its free cash flow over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from ICU Medical's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price16.2% a year
Free cash flow, last 9 years3.6% a year
Revenue, same period21.8% a year
Price to free cash flow47.0x

Fundamental grade

D

Five factors scored 1 to 9 from ICUI's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation5
Profitability3
Growth2
Financial health6
Cash efficiency4

Results from SEC filings

Fiscal years, from ICU Medical's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.

Fiscal year20212022202320242025
Revenue$1.3B$2.3B$2.3B$2.4B$2.2B
Net income$103M-$74M-$30M-$118M$732,000
Free cash flow$199M-$152M$82M$125M$92M
EPS (diluted)$4.74-$3.11-$1.23-$4.83$0.03
Operating margin9.4%-1.9%1.0%1.8%1.9%

Where the revenue comes from

Revenue by products, fiscal 2025. Every breakdown, year by year.

Infusion Consumables$1.1B50%
Infusion Systems$684M31%
Vital Care$438M20%

Superinvestors who own ICUI

From each investor's latest 13F filing (what a 13F shows).

None of the superinvestors we track held ICUI in their latest 13F.

Insider buying

Open-market purchases by ICU Medical's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of ICUI in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when ICUI trades at or below it.

$

New accounts get 7 days of Pro, price alerts included. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does ICU Medical's stock price imply?

At a market value of $4.3B, ICU Medical would need its free cash flow to grow about 16% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 4% a year.

Are ICU Medical insiders buying the stock?

No open-market insider purchases of ICUI in the last 12 months, according to SEC Form 4 filings.

Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.